Swiss National Bank Gilead Sciences, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Swiss National Bank holds 3,697,900 shares of GILD stock, worth $334 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

3,697,900

Previous 3,692,000 0.16%

Holding current value

$334 Million

Previous $253 Million 22.36%

% of portfolio

0.21%

Previous 0.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$66.59 - $83.99 $392,881 - $495,540	5,900 Added 0.16%	3,697,900 $310 Million
Q2 2024 Aug 08, 2024	SELL	$63.15 - $72.88 $2.49 Million - $2.88 Million	-39,500 Reduced 1.06%	3,692,000 $253 Million
Q1 2024 May 07, 2024	SELL	$71.58 - $87.29 $11.8 Million - $14.4 Million	-164,800 Reduced 4.23%	3,731,500 $273 Million
Q4 2023 Feb 06, 2024	SELL	$73.27 - $83.09 $8.49 Million - $9.63 Million	-115,900 Reduced 2.89%	3,896,300 $316 Million
Q3 2023 Nov 08, 2023	SELL	$73.94 - $80.67 $36.8 Million - $40.2 Million	-498,000 Reduced 11.04%	4,012,200 $301 Million
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $35.5 Million - $40.5 Million	-467,300 Reduced 9.39%	4,510,200 $348 Million
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $9.01 Million - $10.3 Million	-116,500 Reduced 2.29%	4,977,500 $413 Million
Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $21.3 Million - $30.6 Million	-341,898 Reduced 6.29%	5,094,000 $437 Million
Q3 2022 Nov 09, 2022	SELL	$59.54 - $68.01 $196,482 - $224,433	-3,300 Reduced 0.06%	5,435,898 $335 Million
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $352,092 - $396,561	6,100 Added 0.11%	5,439,198 $336 Million
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $38.7 Million - $48.4 Million	667,400 Added 14.0%	5,433,098 $323 Million
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $12.5 Million - $14.2 Million	-193,400 Reduced 3.9%	4,765,698 $346 Million
Q3 2021 Nov 08, 2021	SELL	$67.69 - $73.03 $11.2 Million - $12 Million	-164,800 Reduced 3.22%	4,959,098 $346 Million
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $80.5 Million - $88 Million	-1,268,325 Reduced 19.84%	5,123,898 $353 Million
Q1 2021 May 07, 2021	BUY	$60.0 - $68.46 $6.2 Million - $7.07 Million	103,300 Added 1.64%	6,392,223 $413 Million
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $2.9 Million - $3.3 Million	51,200 Added 0.82%	6,288,923 $366 Million
Q3 2020 Nov 09, 2020	BUY	$62.1 - $78.08 $30.4 Million - $38.2 Million	489,800 Added 8.52%	6,237,723 $394 Million
Q2 2020 Aug 05, 2020	BUY	$72.34 - $84.0 $47.5 Million - $55.2 Million	657,100 Added 12.91%	5,747,923 $442 Million
Q1 2020 May 08, 2020	BUY	$62.63 - $80.22 $58.8 Million - $75.3 Million	938,300 Added 22.6%	5,090,823 $381 Million
Q4 2019 Feb 06, 2020	SELL	$61.62 - $67.78 $12.5 Million - $13.8 Million	-203,100 Reduced 4.66%	4,152,523 $270 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $2.01 Million - $2.22 Million	32,199 Added 0.74%	4,355,623 $276 Million
Q2 2019 Aug 02, 2019	SELL	$61.87 - $69.38 $10.2 Million - $11.4 Million	-164,200 Reduced 3.66%	4,323,424 $292 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $6.78 Million - $7.6 Million	108,500 Added 2.48%	4,487,624 $292 Million
Q4 2018 Feb 13, 2019	BUY	$60.54 - $79.0 $3.63 Million - $4.74 Million	60,000 Added 1.39%	4,379,124 $274 Million
Q3 2018 Nov 08, 2018	SELL	$71.28 - $78.92 $13.2 Million - $14.6 Million	-185,300 Reduced 4.11%	4,319,124 $333 Million
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $9.16 Million - $10.7 Million	141,200 Added 3.24%	4,504,424 $319 Million
Q1 2018 May 04, 2018	SELL	$72.84 - $88.8 $44.1 Million - $53.8 Million	-605,800 Reduced 12.19%	4,363,224 $329 Million
Q4 2017 Feb 07, 2018	BUY	$71.15 - $83.52 $10.8 Million - $12.7 Million	151,700 Added 3.15%	4,969,024 $356 Million
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $347 Million - $412 Million	4,817,324	4,817,324 $390 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Gilead Sciences, Inc. Transaction History